These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35503642)

  • 1. Unopposed estrogens: current and future perspectives.
    Montanino Oliva M; Gambioli R; Forte G; Porcaro G; Aragona C; Unfer V
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(8):2975-2989. PubMed ID: 35503642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-Chiro-Inositol in Endometrial Hyperplasia: A Pilot Study.
    Porcaro G; Bilotta G; Capoccia E; Bezerra Espinola MS; Aragona C
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
    Ishihara H; Kitawaki J; Kado N; Koshiba H; Fushiki S; Honjo H
    Fertil Steril; 2003 Mar; 79 Suppl 1():735-42. PubMed ID: 12620485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
    Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of oestrogens and progestogens on the postmenopausal endometrium.
    Whitehead MI
    Maturitas; 1978 Sep; 1(2):87-98. PubMed ID: 755961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone and endometrial cancer.
    Gompel A
    Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():95-107. PubMed ID: 32732107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of D-chiro-Inositol in clinical practice.
    Gambioli R; Forte G; Aragona C; Bevilacqua A; Bizzarri M; Unfer V
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):438-446. PubMed ID: 33506934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the endometrial effects of estrogens and progestins.
    Creasy GW; Kafrissen ME; Upmalis D
    Obstet Gynecol Surv; 1992 Sep; 47(9):654-78. PubMed ID: 1436909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of endometrial cancer with progestogens.
    Gambrell RD
    Maturitas; 1986 Jul; 8(2):159-68. PubMed ID: 3747849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial thickness assessed by transvaginal ultrasound insufficiently predicts occurrence of hyperplasia during unopposed oestrogen use.
    Meuwissen JH; Oddens BJ; Klinkhamer PJ
    Maturitas; 1996 May; 24(1-2):21-30. PubMed ID: 8794430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adenomyosis/endometriosis IVF patient - call for clinical focus.
    Cozzolino M; Alsbjerg B; Pellicer A; Garcia-Velasco JA; Humaidan P
    Reprod Biomed Online; 2024 Apr; 48(4):103737. PubMed ID: 38342076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on the endometrium, endo- and exocervix following the use of local progestogen-releasing delivery systems.
    Johannisson E
    Contraception; 1990 Oct; 42(4):403-21. PubMed ID: 2257741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endometrium--from estrogens alone to TSECs.
    Pickar JH
    Climacteric; 2009 Dec; 12(6):463-77. PubMed ID: 19905899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy.
    Gompel A
    Climacteric; 2018 Aug; 21(4):321-325. PubMed ID: 29583028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenomyosis: the pathophysiology of an oestrogen-dependent disease.
    Kitawaki J
    Best Pract Res Clin Obstet Gynaecol; 2006 Aug; 20(4):493-502. PubMed ID: 16564227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-chiro-inositol, an aromatase down-modulator, increases androgens and reduces estrogens in male volunteers: a pilot study.
    Monastra G; Vazquez-Levin M; Bezerra Espinola MS; Bilotta G; Laganà AS; Unfer V
    Basic Clin Androl; 2021 Jun; 31(1):13. PubMed ID: 34078260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. British Menopause Society tools for clinicians: Progestogens and endometrial protection.
    Hamoda H;
    Post Reprod Health; 2022 Mar; 28(1):40-46. PubMed ID: 34841960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.